About
Shu-Yi Liao, MD, MPH, ScD is an Associate Professor of Medicine in Pulmonary and Critical Care Medicine at UCLA and a physician-scientist focused on translating multi-omics, artificial intelligence, and digital biomarker technologies into clinical applications. He leads the Lung Integrative AI & Omics (LIAO) Laboratory and directs multidisciplinary research in sarcoidosis and interstitial lung disease, including NIH-funded multi-site studies. His innovation interests include breathomics, metabolomics, AI-enabled clinical phenotyping, multimodal biomarker development, and precision monitoring of treatment response. He is developing integrated breath- and blood-based approaches for pulmonary disease and participates in the UCLA Biodesign Accelerator, with an emphasis on translating clinically meaningful technologies toward implementation and commercialization. His professional activities span clinical investigation, biomarker and data-science innovation, multi-institutional collaboration, and mentorship of trainees in biomedical informatics, genomics, and translational research